Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 354

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study

Open access
Dieckmann, Klaus-Peter, Radtke, Arlo, Geczi, Lajos, Matthies, Cord, Anheuser, Petra, Eckardt, Ulrike, Sommer, Jörg, Zengerling, Friedemann, Trenti, Emanuela, Pichler, Renate, Belz, Hanjo, Zastrow, Stefan, Winter, Alexander, Melchior, Sebastian, Hammel, Johannes, Kranz, Jennifer, Bolten, Marius, Krege, Susanne, Haben, Björn, Loidl, Wolfgang, Ruf, Christian Guido, Heinzelbecker, Julia, Heidenreich, Axel, Cremers, Jann Frederik, Oing, Christoph, Hermanns, Thomas, Fankhauser, Christian Daniel, Gillessen, Silke, Reichegger, Hermann, Cathomas, Richard, Pichler, Martin, Hentrich, Marcus, Eredics, Klaus, Lorch, Anja, Wülfing, Christian, Peine, Sven, Wosniok, Werner, Bokemeyer, Carsten, Belge, Gazanfer·2019·Journal of Clinical Oncology

Abstract

PURPOSE: Previous studies suggested that serum levels of microRNA (miR)-371a-3p (so-called M371 test) have a much higher sensitivity and specificity than the classic markers of testicular germ cell tumors (GCTs) and are applicable toward both seminoma and nonseminoma. We sought to confirm the usefulness of this test as a novel biomarker for GCT. PATIENTS AND METHODS: In a prospective, multicentric study, serum samples of 616 patients with testicular GCTs and 258 male controls were examined for serum levels of miRNA-371a-3p (miR levels) by quantitative polymerase chain reaction. The GCT population encompassed 359 patients with seminoma and 257 with nonseminoma; 371 had clinical stage I disease, 201 had systemic disease, and 46 had relapses. Paired measurements before and after orchiectomy were performed in 424 patients; 118 with systemic disease had serial measurements during treatment. miR levels were compared with those of β-human chorionic gonadotropin, α-fetoprotein, and lactate dehydrogenase. RESULTS: For the primary diagnosis of GCT, the M371 test showed a sensitivity of 90.1%, a specificity of 94.0%, an area under the curve of 0.966 upon receiver operating characteristic analysis, and a positive predictive value of 97.2%. α-Fetoprotein, β-human chorionic gonadotropin, and lactate dehydrogenase had sensitivities of less than 50% in seminoma and slightly higher sensitivities in nonseminomas. miR levels were significantly associated with clinical stage, primary tumor size, and response to treatment. Relapses had elevated miR levels that subsequently dropped to normal upon remission. Teratoma did not express miR-371a-3p. CONCLUSION: The M371 test outperforms the classic markers of GCT with both a sensitivity and a specificity greater than 90%. All histologic subgroups, except teratoma, express this marker. The test could be considered for clinical implementation after further validation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1200/jco.18.01480

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 20 references

Cited by

See all 354

Metadata

Authors
Dieckmann, K.-P., Radtke, A., Geczi, L., Matthies, C., Anheuser, P., Eckardt, U., Sommer, J., Zengerling, F., Trenti, E., Pichler, R., Belz, H., Zastrow, S., Winter, A., Melchior, S., Hammel, J., Kranz, J., Bolten, M., Krege, S., Haben, B., Loidl, W., Ruf, C. G., Heinzelbecker, J., Heidenreich, A., Cremers, J. F., Oing, C., Hermanns, T., Fankhauser, C. D., Gillessen, S., Reichegger, H., Cathomas, R., Pichler, M., Hentrich, M., Eredics, K., Lorch, A., Wülfing, C., Peine, S., Wosniok, W., Bokemeyer, C., & Belge, G.
Venue
Journal of Clinical Oncology
Published
2019-06-01
Volume
37
Issue
16
Pages
1412-1423
ISSN
  • 0732-183X (ISSN-L)
  • 1527-7755
OpenAlex
W2922255797
Cited by
354
References
20
FWCI
40.19
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study. https://app.cochat.ai/papers/10.1200/jco.18.01480
The paper
Dieckmann, K.-P., Radtke, A., Geczi, L., Matthies, C., Anheuser, P., Eckardt, U., Sommer, J., Zengerling, F., Trenti, E., Pichler, R., Belz, H., Zastrow, S., Winter, A., Melchior, S., Hammel, J., Kranz, J., Bolten, M., Krege, S., Haben, B., . . . Belge, G. (2019). Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study. Journal of Clinical Oncology. https://doi.org/10.1200/jco.18.01480

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.